Skip to search formSkip to main contentSkip to account menu

CDH13 gene

Known as: Cadherin 13, H-Cadherin (Heart) Gene, CADHERIN, HEART, T-cadherin 
This gene is a mediator of cell-cell adhesion and a negative regulator of neural growth.
National Institutes of Health

Related topics

Related topics

8 relations
Breast CarcinomaCDH13 protein, humanCDH13 wt AlleleCell Adhesion

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Receptor Status
  • 2020
  • Corpus ID: 215531446
2017
2017
CPG-METHYLATION OF THE PROMOTER APC, CDH13, MLH1, MGMT, P16, RASSF1A GENES IN COLORECTAL CANCER PATIENTS
Aim - quantitative analysis of CpG-methylation of oncosuppressor gene APC, CDH13, MLH1, MGMT, P16 and RASSF1A in bi-opsies of… 
2017
2017
Estudio de Asociaciòn de los Genes DGKH (rs1170169, rs9525580), DAT1 (3’UTR-VNTR 40pb), DRD4 (VNTR EXON III 48pb) y CDH13 (rs7187223, rs11646411) en Pacientes Infantiles Colombianos que Presentan…
Las enfermedades de trastorno del comportamiento tienen una prevalencia en ninos de 4,8%-7,4% y en ninas de 2,1% - 3,2% y en… 
2016
2016
Distribution of CDH13, CDH1, MGMT and PTEN promoter methylation and KRAS, BRAF and EGFR mutation in colorectal cancer.
e15073Background: The adenocarcinoma sequence is associated with the accumulation of epigenetic and genetic changes as normal… 
2016
2016
Полиморфизм гена Т-кадгерина (CDH13) ассоциирован с характером манифестации ишемической болезни сердца
2016
2016
The UK10K project identifies rare variants in health and disease
The contribution of rare and low-frequency variants to human traits is largely unexplored. Here we describe insights from… 
2015
2015
[Single Nucleotide Polymorphisms in T-Cadherin Gene (CDH13) Have Cumulative Effect on Body Mass in Patients With Ischemic Heart Disease].
BACKGROUND Low adiponectin concentration observed in obese patients is associated with a high risk of metabolic disorders and… 
2007
2007
유방암에서 연령 변화에 따른 ESR1, PgR, RASSF1A, CDH13, CYP 1B1 유전자의 메틸화 변화
2005
2005
Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer
2001
2001
Advances in Brief Aberrant Promoter Methylation Profile of Bladder Cancer and Its Relationship to Clinicopathological Features 1
We investigated the aberrant promoter methylation profile of bladder cancers and correlated the data with clinicopathological… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)